EarningsQ2 2025 Earnings Report

Cardiff Oncology (XE7C) Q2 2025 Earnings Report

3 Followers

DE:XE7C Q2 2025 EPS Results

Actual EPS-€0.19

Consensus EPS-€0.17

Beat/MissMissed by -€0.02

One Year Ago EPS-€0.23

Actual Revenue€107.98K

Expected Revenue€97.27K

Beat/MissBeat by +€10.71K

YoY Revenue Growth-25.77%

QuarterQ2 2025

Date07/29/2025

TimeAfter Close

Conference CallTuesday, July 29, 2025

DE:XE7C Upcoming Earnings

Cardiff Oncology's next earnings date is estimated for October 29, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Oct 29, 2026	2026 (Q3)	-0.12 / -	-0.152	―
Aug 11, 2026	2026 (Q2)	-0.11 / -0.12	-0.187	33.33% (+0.06)
May 14, 2026	2026 (Q1)	-0.12 / -0.16	-0.178	10.00% (+0.02)
Feb 24, 2026	2025 (Q4)	-0.17 / -0.10	-0.196	50.00% (+0.10)
Nov 06, 2025	2025 (Q3)	-0.18 / -0.15	-0.223	32.00% (+0.07)
Jul 29, 2025	2025 (Q2)	-0.17 / -0.19	-0.232	19.23% (+0.04)
May 08, 2025	2025 (Q1)	-0.17 / -0.18	-0.196	9.09% (+0.02)
Feb 27, 2025	2024 (Q4)	-0.22 / -0.20	-0.187	-4.76% (>-0.01)
Nov 07, 2024	2024 (Q3)	-0.24 / -0.22	-0.196	-13.64% (-0.03)
Aug 08, 2024	2024 (Q2)	-0.22 / -0.23	-0.223	-4.00% (>-0.01)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed